Atiprimod
Atiprimod (INN, codenamed SK&F106615) is a substance being studied in the treatment of certain multiple myelomas and other advanced cancers. It may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. This drug is also being researched as a potential treatment for various autoimmune diseases. It was first developed by GlaxoSmithKline as a potential treatment for rheumatoid arthritis. The substance is also known as azaspirane, although this more properly refers to the class of chemicals to which atiprimod belongs.
Wikipage redirect
primaryTopic
Atiprimod
Atiprimod (INN, codenamed SK&F106615) is a substance being studied in the treatment of certain multiple myelomas and other advanced cancers. It may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. This drug is also being researched as a potential treatment for various autoimmune diseases. It was first developed by GlaxoSmithKline as a potential treatment for rheumatoid arthritis. The substance is also known as azaspirane, although this more properly refers to the class of chemicals to which atiprimod belongs.
has abstract
Atiprimod (INN, codenamed SK&F ...... cell lymphoma cells in vitro.
@en
ATC prefix
CAS number
123018-47-3
FDA UNII code
MG7D3QD743
IUPAC name
3-(8,8-dipropyl-3-azaspiro[4.5]decan-3-yl)-N,N- diethylpropan-1-amine
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
14,416,361
Wikipage revision ID
737,160,862
Alt
Ball-and-stick model of the atiprimod molecule
ChEMBL
ChemSpiderID
molecular weight
3.36598e+2
smiles
StdInChIKey
SERHTTSLBVGRBY-UHFFFAOYSA-N
Verifiedfields
verifiedrevid
458,780,494
hypernym
comment
Atiprimod (INN, codenamed SK&F ...... ls to which atiprimod belongs.
@en
label
Atiprimod
@en